ABBV 8-K 2026-09-03

AbbVie Inc. (ABBV) 8-K dated 2026-09-03 — accession 0001104659-26-104940. This URL is the filing, not the ABBV hub.

AbbVie Inc. (ABBV) is a drug manufacturers - general company listed on US. It is led by Rob Michael.

AbbVie Inc. filed a 8-K on 2026-09-03. Accession 0001104659-26-104940.

Cached items: 7.01, 9.01. EDGAR remains the official archive; Lician keeps this accession as its own indexable page so Google can recrawl the form, not a ticker dump.

Latest reported ABBV revenue for 2025-12-31 was $61.16B. Net income was $4.23B. Revenue was up 8.6% from 2024-12-31 to 2025-12-31. ABBV currently screens at market cap $334.34B.

Not investment advice. The ABBV SEC hub lists recent forms. The stock page is the research view.